CHF70.80
CHF0.00 (0.00%)
End-of-day quote: 06/01/2024
SWX:COPN

Cosmo Pharmaceuticals N.V. Annual Report

Year Year 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Rev. Revenue
CHF96.72M CHF102.09M CHF65.07M CHF60.95M CHF62.50M CHF65.62M CHF67.71M CHF68.39M CHF60.63M CHF79.64M CHF57.39M CHF59.60M CHF33.78M CHF32.05M CHF26.69M CHF34.21M CHF22.42M
GM % Gross Margin %
59.33% 60.34% 49.32% 54.69% 59.91% 66.38% 67.53% 70.98% 66.84% 72.95% 66.61% 72.83% 57.10% 55.30% 52.13% 61.40% 41.28%
OM Operating Margin
12.64% 27.48% 17.06% 2.96% -19.69% -25.33% -14.18% 37.13% -8.96% 27.89% 22.54% 44.50% 26.37% 14.98% 16.65% 32.70% -1.11%
EPS Earnings Per Share
CHF0.00 CHF0.07 CHF1.05 CHF1.31 CHF-0.55 CHF-1.67 CHF-1.20 CHF-2.19 CHF1.37 CHF-0.24 CHF2.02 CHF4.80 CHF1.40 CHF0.53 CHF0.24 CHF0.27 CHF0.68 CHF-0.17
Div. Dividends
CHF2.00 CHF1.05 CHF0.00 CHF0.00 CHF0.00 CHF0.00 CHF1.50 CHF1.50 CHF1.40 CHF1.00 CHF1.00 CHF0.00 CHF0.00 CHF0.00 CHF0.00 CHF0.00 CHF0.00
PR % Payout Ratio %
2857.14% 100.00% 0.00% -0.00% -0.00% -0.00% -68.49% 109.49% -583.33% 49.50% 20.83% 0 0 0.00% 0.00% 0.00% -0.00%
Sha. Shares
16.05m 16.26m 16.71m 14.43m 14.52m 14.84m 15.04m 14.1m 14.1m 14.1m 14.85m 14m 13.5m 14.74m 13.72m 13.88m 13.88m
OCF Operating Cash Flow
CHF33.62M CHF33.23M CHF12.61M CHF12.99M CHF-18.85M CHF-10.16M CHF-9.43M CHF21.69M CHF-39.26M CHF66.45M CHF8.11M CHF23.00M CHF11.29M CHF7.79M CHF3.88M CHF12.52M CHF-2.49M
FCF Free Cash Flow
CHF45.55M CHF28.71M CHF7.12M CHF8.87M CHF-21.09M CHF-12.06M CHF-22.30M CHF7.98M CHF-41.13M CHF64.25M CHF6.16M CHF20.94M CHF10.18M CHF6.71M CHF2.65M CHF11.15M CHF-3.44M
FCFS Free Cash Flow Per Share
CHF1.14 CHF1.58 CHF0.25 CHF0.34 CHF-2.47 CHF-1.32 CHF-2.12 CHF0.23 CHF-2.96 CHF4.46 CHF0.39 CHF1.46 CHF0.55 CHF0.03 CHF-0.21 CHF0.51 CHF-0.27